(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: Former microbiologist Darnisha Grant Harrison, CEO of Ennaid Therapeutics, on developing a technology that shows 99% effectiveness against the Zika virus, and the company's plans to be the first-to-market with a cure.

Chip Stocks’ Best Quarter Ever Is Ending With Some Wild Swings
22:33

Supreme Court Thwarts Trump Bid to Oust Fed’s Cook
20:43

AI Cost Reality Check Hits Tech Stocks as Apple Hikes Price
20:23